PofoliaShared via Pofolia

Cell· 2026Q1· Review

Hallmarks of cancer—Then and now, and beyond

Douglas Hanahan

Short summary

This review synthesizes the evolution of the 'hallmarks of cancer' concept over 25 years, proposing that mechanism-guided co-targeting of these hallmarks offers impactful new therapeutic strategies.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Cancer's complexity can be organized into dimensions: acquired functional capabilities (hallmarks), enabling phenotypic characteristics, hallmark-conveying cells, and systemic interactions.
  • The 'hallmarks of cancer' concept has been refined over the past 25 years.
  • A hypothesis proposes that co-targeting these hallmarks based on their underlying mechanisms could yield effective new cancer therapies.

AI-generated from the title and abstract; the full text is not read.

Abstract

Cancer presents a remarkably instructive perturbation of mechanisms manifesting in our biology that have gone awry, eliciting a malady that is inexorably increasing in incidence and societal burden concomitant with healthier aging. The wealth of knowledge and data forthcoming from decades of cancer research can be organized into conceptually distinct but interconnected parametric dimensions that define the mechanistic foundation of the disease: aberrantly acquired functional capabilities (the hallmarks of cancer), enabling phenotypic characteristics, hallmark-conveying cells populating cancer microenvironments, and systemic interactions. Collectively, they provide a logical framework with which to illuminate the operating systems of these outlaw organs, from inception through multistage tumorigenesis to adaptive evolution. This review presents a concise synthesis of the hallmark conceptualization as it has been refined during the past 25 years, including a corollary hypothesis that mechanism-guided hallmark co-targeting could offer impactful new therapeutic strategies for treating human cancers.

The authors' abstract, as published at the source. Cell, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Oncology

OncologyMedicine